Skip to Content
Merck
  • SYCP2 Translocation-Mediated Dysregulation and Frameshift Variants Cause Human Male Infertility.

SYCP2 Translocation-Mediated Dysregulation and Frameshift Variants Cause Human Male Infertility.

American journal of human genetics (2019-12-24)
Samantha L P Schilit, Shreya Menon, Corinna Friedrich, Tammy Kammin, Ellen Wilch, Carrie Hanscom, Sizun Jiang, Sabine Kliesch, Michael E Talkowski, Frank Tüttelmann, Amy J MacQueen, Cynthia C Morton
ABSTRACT

Unexplained infertility affects 2%-3% of reproductive-aged couples. One approach to identifying genes involved in infertility is to study subjects with this clinical phenotype and a de novo balanced chromosomal aberration (BCA). While BCAs may reduce fertility by production of unbalanced gametes, a chromosomal rearrangement may also disrupt or dysregulate genes important in fertility. One such subject, DGAP230, has severe oligozoospermia and 46,XY,t(20;22)(q13.3;q11.2). We identified exclusive overexpression of SYCP2 from the der(20) allele that is hypothesized to result from enhancer adoption. Modeling the dysregulation in budding yeast resulted in disrupted structural integrity of the synaptonemal complex, a common cause of defective spermatogenesis in mammals. Exome sequencing of infertile males revealed three heterozygous SYCP2 frameshift variants in additional subjects with cryptozoospermia and azoospermia. In sum, this investigation illustrates the power of precision cytogenetics for annotation of the infertile genome, suggests that these mechanisms should be considered as an alternative etiology to that of segregation of unbalanced gametes in infertile men harboring a BCA, and provides evidence of SYCP2-mediated male infertility in humans.

MATERIALS
Product Number
Brand
Product Description

Sigma-Aldrich
Anti-SYCP2, serum, from rabbit
Sigma-Aldrich
β-Estradiol, powder, γ-irradiated, suitable for cell culture